For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of TRIMURTHI DRUGS. For more details, see the TRIMURTHI DRUGS quarterly results and TRIMURTHI DRUGS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.0 |
No. of shares | m | 8.10 |
1 Week | % | 0.0 |
1 Month | % | 0.0 |
1 Year | % | - |
52 week H/L | Rs | 17.2/8.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
TRIMURTHI DRUGS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 8 | 7 | 7 | 11 | 11 | |
Low | Rs | 7 | 2 | 2 | 5 | 7 | |
Sales per share (Unadj.) | Rs | 12.2 | 12.6 | 11.4 | 10.6 | 1.7 | |
Earnings per share (Unadj.) | Rs | -0.2 | -0.3 | -4.6 | -2.6 | -0.1 | |
Diluted earnings per share | Rs | -0.2 | -0.3 | -4.6 | -2.6 | -0.1 | |
Cash flow per share (Unadj.) | Rs | 0.1 | -0.1 | -4.4 | -2.5 | 0 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 13.5 | 13.1 | 8.5 | 9.1 | 8.9 | |
Adj. book value per share | Rs | 13.5 | 13.1 | 8.5 | 9.1 | 8.9 | |
Shares outstanding (eoy) | m | 8.10 | 8.10 | 8.10 | 8.10 | 8.10 | |
Price / Sales ratio | x | 0.6 | 0.3 | 0.4 | 0.8 | 5.2 | |
Avg P/E ratio | x | -39.9 | -13.8 | -1.0 | -3.1 | -122.7 | |
P/CF ratio (eoy) | x | 90.9 | -52.9 | -1.0 | -3.2 | -1,963.5 | |
Price / Book Value ratio | x | 0.5 | 0.3 | 0.5 | 0.9 | 1.0 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 59 | 36 | 36 | 65 | 74 | |
Total wages/salary | Rs m | 7 | 7 | 7 | 4 | 2 |
TRIMURTHI DRUGS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 99 | 102 | 93 | 86 | 14 | |
Other income | Rs m | 10 | 6 | 3 | 6 | 5 | |
Total revenues | Rs m | 108 | 108 | 96 | 92 | 19 | |
Gross profit | Rs m | -7 | -5 | -38 | -25 | -5 | |
Depreciation | Rs m | 2 | 2 | 2 | 1 | 1 | |
Interest | Rs m | 1 | 1 | 1 | 1 | 0 | |
Profit before tax | Rs m | -1 | -2 | -37 | -21 | -1 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | -1 | -3 | -37 | -21 | -1 | |
Gross profit margin | % | -7.4 | -4.9 | -41.0 | -29.2 | -36.8 | |
Effective tax rate | % | -19.2 | -20.5 | -0.4 | 0.4 | -2.5 | |
Net profit margin | % | -1.5 | -2.5 | -40.4 | -24.6 | -4.3 |
TRIMURTHI DRUGS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 107 | 114 | 73 | 59 | 42 | |
Current liabilities | Rs m | 10 | 18 | 22 | 9 | 1 | |
Net working cap to sales | % | 98.5 | 93.6 | 55.7 | 58.1 | 297.6 | |
Current ratio | x | 10.9 | 6.3 | 3.4 | 6.4 | 68.4 | |
Inventory Days | Days | 26 | 18 | 23 | 96 | 721 | |
Debtors Days | Days | 121,382,048 | 46,667,406 | 54,423 | 52,217 | 49,478 | |
Net fixed assets | Rs m | 26 | 23 | 22 | 27 | 29 | |
Share capital | Rs m | 81 | 81 | 81 | 81 | 81 | |
"Free" reserves | Rs m | 28 | 25 | -12 | -7 | -9 | |
Net worth | Rs m | 109 | 106 | 69 | 74 | 72 | |
Long term debt | Rs m | 9 | 8 | 0 | 1 | 0 | |
Total assets | Rs m | 133 | 137 | 96 | 87 | 72 | |
Interest coverage | x | 0.1 | -0.7 | -53.0 | -34.4 | 0 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.7 | 0.7 | 1.0 | 1.0 | 0.2 | |
Return on assets | % | -0.1 | -1.0 | -38.4 | -23.7 | -0.8 | |
Return on equity | % | -1.4 | -2.4 | -54.5 | -28.5 | -0.8 | |
Return on capital | % | 0.1 | -0.8 | -53.3 | -27.4 | -0.8 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
TRIMURTHI DRUGS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -5 | 6 | 16 | 16 | 1 | |
From Investments | Rs m | 4 | 5 | 1 | -8 | 1 | |
From Financial Activity | Rs m | -0 | -2 | -8 | 0 | 0 | |
Net Cashflow | Rs m | -2 | 9 | 10 | 8 | 2 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Aditya Bhangadia | COMP SEC: Nishita Kalantri | YEAR OF INC: 1994 | BSE CODE: 536565 | FV (Rs): 10 | DIV YIELD (%): - |
More Trading Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare TRIMURTHI DRUGS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.